Selective PPARδ agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway is a research paper published in Journal of Biological Chemistry (2022). On theSindex it has a DataRank of 0. It has been cited 60 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R37 AA020703
National Institutes of Health
Grant: R01 AA24726
National Institutes of Health
Grant: P30 DK120515
National Institutes of Health
Grant: U01AA022614
National Institutes of Health
Grant: R01DK091183
National Institutes of Health
Grant: U01AA018663
National Institutes of Health
Grant: P50 AA011999
National Institutes of Health
Grant: R01DK111866
National Institutes of Health
Grant: R01DK099205
National Institutes of Health
Grant: U01AA029019
National Institutes of Health
Grant: R01AA028550
National Institutes of Health
Grant: R01DK09920
National Institutes of Health
Grant: R01DK101737
National Institutes of Health
Grant: U01 AA026939-04S1
NIAAA NIH HHS
Grant: R01 AA024726
NIDDK NIH HHS
Grant: F32 DK009920
BLRD VA
Grant: I01 BX004594
NIAAA NIH HHS
Grant: U01 AA026939
VA Biomedical Laboratory Research and Development
University of California, San Diego
FWCI
3.92
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals